Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is an anilide, belonging to the class of organic compounds known as anilides. It is derived from oxoacids and is characterized by its complex structure, which includes a phenyl ring substituted with a chloro group and a pyridin-3-yloxymethyl group. The compound also features a cyclohexene ring with a morpholinyl group. However, specific details about its mechanism of action, developer, or primary indication are not available in the provided sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on N-[4-chloro-3-(pyridin-3-yloxymethyl)-phenyl]-3-fluoro-.